Science & Environnement
optional screen reader
Covid-19 Vaccination Cards Are the Only Proof of Shots, Soon an Essential
The U.S. lacks a central database for immunizations due to privacy concerns, leaving non-standardized impermanent cards as the sole record of shots
-
Introducing ‘Vaxzevria’: AstraZeneca renames Covid vaccine as firm fights off controversy over drug
AstraZeneca has renamed its Covid-19 vaccine, a move that coincides with the company’s struggle to reassure the public that its drug is safe, following numerous reports of potential adverse effects.
-
Pfizer begins early stage clinical trial testing oral antiviral drug for Covid
Pfizer said it has begun an early stage clinical trial testing its experimental oral antiviral drug for Covid-19.
-
AstraZeneca says US data shows COVID-19 vaccine prevents 79% of symptomatic disease
It would be the fourth vaccine authorized for use in the U.S., alongside ones from Pfizer-BioNTech, Moderna, and Johnson & Johnson.